Page last updated: 2024-08-22

3-coumaranone and warfarin

3-coumaranone has been researched along with warfarin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alipour, M; Foroumadi, A; Ghandi, M; Khoobi, M; Moradi, A; Nadri, H; Sakhteman, A; Shafiee, A1
He, Q; Li, JQ; Liu, R; Liu, S; Lu, X; Shu, C; Ye, LW; Yu, YF1
Cheng, CH; Gandeepan, P; Kuppusamy, R1
Legoabe, LJ; Petzer, A; Petzer, JP; Van Dyk, AS1

Other Studies

4 other study(ies) available for 3-coumaranone and warfarin

ArticleYear
Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Archiv der Pharmazie, 2013, Volume: 346, Issue:8

    Topics: Acetylcholinesterase; Antioxidants; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumarins; Drug Design; Kinetics; Molecular Docking Simulation; Molecular Structure; Protein Conformation; Structure-Activity Relationship

2013
Practical, modular, and general synthesis of 3-coumaranones through gold-catalyzed intermolecular alkyne oxidation strategy.
    Chemistry, an Asian journal, 2015, Volume: 10, Issue:1

    Topics: Alkynes; Biological Products; Catalysis; Coumarins; Crystallography, X-Ray; Cyclization; Gold; Molecular Conformation; Oxidation-Reduction

2015
Rh(III)-Catalyzed [4 + 1] Annulations of 2-Hydroxy- and 2-Aminobenzaldehydes with Allenes: A Simple Method toward 3-Coumaranones and 3-Indolinones.
    Organic letters, 2015, Aug-07, Volume: 17, Issue:15

    Topics: Alkadienes; Benzaldehydes; Catalysis; Coumarins; Indoles; Molecular Structure; Rhodium; Stereoisomerism

2015
3-Coumaranone derivatives as inhibitors of monoamine oxidase.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Coumarins; Dose-Response Relationship, Drug; Drug Design; Humans; Isoenzymes; Models, Biological; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Recombinant Proteins; Structure-Activity Relationship

2015